| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of protein modification process | BLM SLFN12L IBTK HEG1 CENPE VCAN CEP295 SPAG9 LRRK1 CMYA5 EIF2AK1 YWHAB HSPA2 PTK2 IL6ST | 2.55e-05 | 1488 | 62 | 15 | GO:0031399 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | BLM SLFN12L IBTK HEG1 CENPE VCAN SPAG9 LRRK1 CMYA5 EIF2AK1 YWHAB HSPA2 PTK2 IL6ST | 6.45e-05 | 1421 | 62 | 14 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | BLM SLFN12L IBTK HEG1 CENPE VCAN SPAG9 LRRK1 CMYA5 EIF2AK1 YWHAB HSPA2 PTK2 IL6ST | 6.55e-05 | 1423 | 62 | 14 | GO:0051174 |
| Domain | AT_hook | 8.73e-05 | 27 | 60 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.73e-05 | 27 | 60 | 3 | IPR017956 | |
| Domain | EGF_3 | 1.06e-04 | 235 | 60 | 6 | PS50026 | |
| Domain | EGF-like_dom | 1.45e-04 | 249 | 60 | 6 | IPR000742 | |
| Domain | EGF_1 | 1.65e-04 | 255 | 60 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.87e-04 | 261 | 60 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.03e-04 | 265 | 60 | 6 | PS01186 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.74e-04 | 106 | 60 | 4 | IPR000152 | |
| Domain | EGF_CA | 6.37e-04 | 122 | 60 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.77e-04 | 124 | 60 | 4 | IPR001881 | |
| Domain | Disintegrin_CS | 1.18e-03 | 16 | 60 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.50e-03 | 18 | 60 | 2 | PF08516 | |
| Domain | - | 1.86e-03 | 20 | 60 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 2.05e-03 | 21 | 60 | 2 | PF00200 | |
| Domain | DISIN | 2.05e-03 | 21 | 60 | 2 | SM00050 | |
| Domain | BTB | 2.67e-03 | 180 | 60 | 4 | SM00225 | |
| Domain | BTB/POZ_dom | 2.95e-03 | 185 | 60 | 4 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 3.18e-03 | 189 | 60 | 4 | IPR011333 | |
| Domain | ACR | 3.38e-03 | 27 | 60 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 3.38e-03 | 27 | 60 | 2 | IPR006586 | |
| Domain | ZF_PHD_2 | 3.54e-03 | 95 | 60 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 3.64e-03 | 96 | 60 | 3 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 3.75e-03 | 97 | 60 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.97e-03 | 99 | 60 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.09e-03 | 100 | 60 | 3 | PS00010 | |
| Domain | HMGI/Y_DNA-bd_CS | 4.44e-03 | 31 | 60 | 2 | IPR000637 | |
| Domain | ConA-like_dom | 5.37e-03 | 219 | 60 | 4 | IPR013320 | |
| Domain | EGF | 6.87e-03 | 235 | 60 | 4 | SM00181 | |
| Domain | Peptidase_M12B_N | 6.97e-03 | 39 | 60 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.97e-03 | 39 | 60 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 7.32e-03 | 40 | 60 | 2 | PS00427 | |
| Domain | Reprolysin | 7.32e-03 | 40 | 60 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 7.32e-03 | 40 | 60 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.32e-03 | 40 | 60 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 7.32e-03 | 40 | 60 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 7.68e-03 | 41 | 60 | 2 | IPR001762 | |
| Domain | EGF | 7.75e-03 | 126 | 60 | 3 | PF00008 | |
| Domain | BTB | 8.62e-03 | 131 | 60 | 3 | PF00651 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.06e-04 | 271 | 40 | 6 | MM15388 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION | 1.17e-04 | 6 | 40 | 2 | M47444 | |
| Pathway | PID_ATM_PATHWAY | 1.19e-04 | 34 | 40 | 3 | M84 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.56e-04 | 291 | 40 | 6 | M16647 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.25e-04 | 42 | 40 | 3 | M48018 | |
| Pubmed | 3.42e-06 | 686 | 62 | 9 | 29987050 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 7.13e-06 | 564 | 62 | 8 | 21565611 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 19056739 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KMT2C IBTK HOOK1 CNOT10 ZBTB21 SPAG9 ASXL2 LRRK1 CMYA5 YWHAB PTK2 | 1.50e-05 | 1284 | 62 | 11 | 17353931 |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 27736841 | ||
| Pubmed | KMT2C SLFN12L PSME4 VCAN AFF1 CEP295 ASXL2 ZMYM1 FAM171B GOLGB1 | 2.05e-05 | 1084 | 62 | 10 | 11544199 | |
| Pubmed | 2.34e-05 | 31 | 62 | 3 | 20813000 | ||
| Pubmed | 2.98e-05 | 335 | 62 | 6 | 15741177 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 16227609 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 33596429 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 26992741 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 12975363 | ||
| Pubmed | 3.19e-05 | 339 | 62 | 6 | 37232246 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.58e-05 | 208 | 62 | 5 | 33230847 | |
| Pubmed | BLM KMT2C LIMA1 KANSL1 CNOT10 EPC1 ZBTB21 SPAG9 ASXL2 ZMYM1 MDM2 | 4.01e-05 | 1429 | 62 | 11 | 35140242 | |
| Pubmed | A critical role for noncoding 5S rRNA in regulating Mdmx stability. | 4.67e-05 | 6 | 62 | 2 | 21925390 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 22304915 | ||
| Pubmed | 5.02e-05 | 963 | 62 | 9 | 28671696 | ||
| Pubmed | 6.25e-05 | 234 | 62 | 5 | 36243803 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 6.44e-05 | 120 | 62 | 4 | 31413325 | |
| Pubmed | Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. | 6.53e-05 | 7 | 62 | 2 | 19821490 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.80e-05 | 774 | 62 | 8 | 15302935 | |
| Pubmed | 8.56e-05 | 1285 | 62 | 10 | 35914814 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 36503900 | ||
| Pubmed | Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding. | 8.69e-05 | 8 | 62 | 2 | 18356162 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | BLM RANBP10 LIMA1 HOOK1 BBS7 CNOT10 ZBTB21 SPAG9 PFKFB2 EIF2AK1 | 1.08e-04 | 1321 | 62 | 10 | 27173435 |
| Pubmed | Common genetic variants in candidate genes and risk of familial lymphoid malignancies. | 1.34e-04 | 145 | 62 | 4 | 19573080 | |
| Pubmed | 1.38e-04 | 277 | 62 | 5 | 30745168 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 24244196 | ||
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 1.39e-04 | 10 | 62 | 2 | 22421440 | |
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 1.39e-04 | 10 | 62 | 2 | 19815555 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.41e-04 | 444 | 62 | 6 | 34795231 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.42e-04 | 861 | 62 | 8 | 36931259 | |
| Pubmed | 1.44e-04 | 446 | 62 | 6 | 24255178 | ||
| Pubmed | 1.57e-04 | 151 | 62 | 4 | 17043677 | ||
| Pubmed | Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression. | 1.70e-04 | 11 | 62 | 2 | 22734001 | |
| Pubmed | Peli1 Modulates the Subcellular Localization and Activity of Mdmx. | 2.04e-04 | 12 | 62 | 2 | 29523541 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 20018852 | ||
| Pubmed | 2.29e-04 | 486 | 62 | 6 | 20936779 | ||
| Pubmed | A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis. | 2.41e-04 | 13 | 62 | 2 | 32929379 | |
| Pubmed | Furin, a transcriptional target of NKX2-5, has an essential role in heart development and function. | 2.41e-04 | 13 | 62 | 2 | 30840660 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 21502505 | ||
| Pubmed | MOF-associated complexes ensure stem cell identity and Xist repression. | 2.41e-04 | 13 | 62 | 2 | 24842875 | |
| Pubmed | Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. | 2.41e-04 | 13 | 62 | 2 | 18206965 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 38018454 | ||
| Pubmed | 3.60e-04 | 529 | 62 | 6 | 14621295 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 4.51e-04 | 552 | 62 | 6 | 10737800 | |
| Pubmed | 4.58e-04 | 777 | 62 | 7 | 35844135 | ||
| Pubmed | 4.61e-04 | 360 | 62 | 5 | 33111431 | ||
| Pubmed | Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. | 4.64e-04 | 84 | 62 | 3 | 19237606 | |
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 4.70e-04 | 18 | 62 | 2 | 11149944 | |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 4.70e-04 | 18 | 62 | 2 | 17500065 | |
| Pubmed | 5.14e-04 | 87 | 62 | 3 | 17979178 | ||
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 28526753 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 5.74e-04 | 1061 | 62 | 8 | 33845483 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 5.82e-04 | 20 | 62 | 2 | 29785026 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.27e-04 | 588 | 62 | 6 | 38580884 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.25e-04 | 398 | 62 | 5 | 35016035 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 7.49e-04 | 1105 | 62 | 8 | 35748872 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 7.94e-04 | 853 | 62 | 7 | 28718761 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 8.16e-04 | 857 | 62 | 7 | 25609649 | |
| Pubmed | 8.40e-04 | 103 | 62 | 3 | 10574462 | ||
| Pubmed | A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. | 8.41e-04 | 24 | 62 | 2 | 16620772 | |
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 24947832 | ||
| Pubmed | 9.88e-04 | 1442 | 62 | 9 | 35575683 | ||
| Pubmed | 9.89e-04 | 26 | 62 | 2 | 23435420 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 9.96e-04 | 1155 | 62 | 8 | 20360068 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.02e-03 | 430 | 62 | 5 | 35044719 | |
| Pubmed | 1.07e-03 | 1168 | 62 | 8 | 19946888 | ||
| Pubmed | 1.13e-03 | 255 | 62 | 4 | 15324660 | ||
| Pubmed | 1.15e-03 | 28 | 62 | 2 | 17974005 | ||
| Pubmed | 1.18e-03 | 116 | 62 | 3 | 21282530 | ||
| Pubmed | 1.26e-03 | 263 | 62 | 4 | 34702444 | ||
| Pubmed | Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. | 1.26e-03 | 263 | 62 | 4 | 19773279 | |
| Pubmed | 1.28e-03 | 119 | 62 | 3 | 24162774 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 1.28e-03 | 1496 | 62 | 9 | 32877691 | |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 1.29e-03 | 453 | 62 | 5 | 27113764 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.34e-03 | 934 | 62 | 7 | 33916271 | |
| Pubmed | 1.41e-03 | 31 | 62 | 2 | 15960975 | ||
| Pubmed | 1.42e-03 | 689 | 62 | 6 | 36543142 | ||
| Pubmed | 1.43e-03 | 124 | 62 | 3 | 35516420 | ||
| Pubmed | 1.76e-03 | 288 | 62 | 4 | 23383273 | ||
| Interaction | BIN1 interactions | 2.80e-06 | 129 | 62 | 6 | int:BIN1 | |
| Interaction | HNF4A interactions | 2.11e-05 | 275 | 62 | 7 | int:HNF4A | |
| Interaction | RRM2B interactions | 2.12e-05 | 53 | 62 | 4 | int:RRM2B | |
| Interaction | PPM1H interactions | 3.82e-05 | 123 | 62 | 5 | int:PPM1H | |
| Interaction | MPRIP interactions | 5.01e-05 | 214 | 62 | 6 | int:MPRIP | |
| Interaction | CSK interactions | RANBP10 IBTK MIA2 HOOK1 ATP11C PFKFB2 CMYA5 PP2D1 YWHAB PTK2 GOLGA4 | 5.61e-05 | 861 | 62 | 11 | int:CSK |
| Interaction | HSPH1 interactions | 6.62e-05 | 448 | 62 | 8 | int:HSPH1 | |
| Interaction | AFDN interactions | 7.12e-05 | 333 | 62 | 7 | int:AFDN | |
| Interaction | EIF2AK1 interactions | 8.60e-05 | 28 | 62 | 3 | int:EIF2AK1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 1.79e-04 | 206 | 62 | 4 | chr15q26 | |
| Cytoband | 15q26.3 | 1.42e-03 | 41 | 62 | 2 | 15q26.3 | |
| Cytoband | 15q26.1 | 2.45e-03 | 54 | 62 | 2 | 15q26.1 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.69e-06 | 856 | 62 | 11 | M4500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CCDC170 BLM TBX22 LIMA1 KANSL1 HOOK1 CENPE CEP295 ASXL2 ZMYM1 TTC1 MDM2 GOLGB1 MAP3K19 | 7.41e-07 | 989 | 62 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.09e-06 | 330 | 62 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | BLM HEG1 PHF20 PSME4 HOOK1 CENPE BBS7 FAT3 ATP11C CEP295 ZMYM1 XRCC2 FAM171B | 9.42e-06 | 1060 | 62 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.16e-05 | 194 | 62 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 2.37e-05 | 408 | 62 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BLM MMRN1 LIMA1 HEG1 MIA2 PSME4 CENPE VCAN AFF1 ATP11C CEP295 ASXL2 ZMYM1 | 5.41e-05 | 1252 | 62 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.75e-05 | 339 | 62 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.77e-05 | 146 | 62 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.78e-05 | 369 | 62 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.12e-04 | 261 | 62 | 6 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 1.21e-04 | 165 | 62 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 1.25e-04 | 266 | 62 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | BLM HEG1 PHF20 PSME4 HOOK1 CENPE BBS7 FAT3 ATP11C CEP295 ZMYM1 XRCC2 FAM171B | 1.85e-04 | 1414 | 62 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_100 | 2.09e-04 | 100 | 62 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 2.40e-04 | 427 | 62 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.58e-04 | 432 | 62 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.72e-04 | 107 | 62 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.90e-04 | 311 | 62 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.24e-04 | 595 | 62 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 3.82e-04 | 117 | 62 | 4 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 4.04e-04 | 778 | 62 | 9 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | 4.36e-04 | 786 | 62 | 9 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.68e-04 | 629 | 62 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.59e-04 | 230 | 62 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 5.81e-04 | 818 | 62 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.51e-04 | 831 | 62 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 7.46e-04 | 14 | 62 | 2 | gudmap_kidney_e13.5_Podocyte_MafB_k1_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.79e-04 | 375 | 62 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-07 | 193 | 62 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 176 | 62 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Endothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 5.36e-06 | 181 | 62 | 5 | 4fe0215d08f03d4e24749d70fce01b7aa22906fd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-06 | 182 | 62 | 5 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-06 | 189 | 62 | 5 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.61e-06 | 189 | 62 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-06 | 190 | 62 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 191 | 62 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 191 | 62 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-06 | 191 | 62 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.14e-06 | 192 | 62 | 5 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.32e-06 | 193 | 62 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.50e-06 | 194 | 62 | 5 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.69e-06 | 195 | 62 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.89e-06 | 196 | 62 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.08e-06 | 197 | 62 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.28e-06 | 198 | 62 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.49e-06 | 199 | 62 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.70e-06 | 200 | 62 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.70e-06 | 200 | 62 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 8.70e-06 | 200 | 62 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.70e-06 | 200 | 62 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.38e-05 | 120 | 62 | 4 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-05 | 155 | 62 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-05 | 155 | 62 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 155 | 62 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.63e-05 | 156 | 62 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.05e-05 | 164 | 62 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.44e-05 | 166 | 62 | 4 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 8.64e-05 | 167 | 62 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 9.04e-05 | 169 | 62 | 4 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 9.04e-05 | 169 | 62 | 4 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-05 | 170 | 62 | 4 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.25e-05 | 170 | 62 | 4 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-05 | 171 | 62 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.46e-05 | 171 | 62 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-05 | 171 | 62 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.68e-05 | 172 | 62 | 4 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.06e-04 | 176 | 62 | 4 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-9|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 177 | 62 | 4 | ae55773c531099a9e94f44f01ba48b5e71dddc53 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 178 | 62 | 4 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 178 | 62 | 4 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 180 | 62 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.18e-04 | 181 | 62 | 4 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.20e-04 | 182 | 62 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 182 | 62 | 4 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 182 | 62 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 184 | 62 | 4 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 185 | 62 | 4 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 1.28e-04 | 185 | 62 | 4 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-04 | 185 | 62 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 62 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-04 | 186 | 62 | 4 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-04 | 186 | 62 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 186 | 62 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 1.34e-04 | 187 | 62 | 4 | 8d7fa6b2950898e7f283401808378ba2a41b9651 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.36e-04 | 188 | 62 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.36e-04 | 188 | 62 | 4 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.36e-04 | 188 | 62 | 4 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.36e-04 | 188 | 62 | 4 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 189 | 62 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 189 | 62 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.39e-04 | 189 | 62 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 189 | 62 | 4 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.39e-04 | 189 | 62 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 189 | 62 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.39e-04 | 189 | 62 | 4 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 189 | 62 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 1.39e-04 | 189 | 62 | 4 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 190 | 62 | 4 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 190 | 62 | 4 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.42e-04 | 190 | 62 | 4 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.42e-04 | 190 | 62 | 4 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 1.42e-04 | 190 | 62 | 4 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 190 | 62 | 4 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.42e-04 | 190 | 62 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-04 | 191 | 62 | 4 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 191 | 62 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 1.45e-04 | 191 | 62 | 4 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 191 | 62 | 4 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-04 | 191 | 62 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 192 | 62 | 4 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.13e-05 | 49 | 43 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.30e-05 | 190 | 62 | 6 | 5080_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.46e-05 | 194 | 62 | 6 | 3143_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 5775_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.74e-05 | 200 | 62 | 6 | 5480_DN | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 4.33e-05 | 5 | 62 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Stage IV Skin Melanoma | 9.06e-05 | 7 | 62 | 2 | C1321872 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 2.83e-04 | 12 | 62 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 4.88e-04 | 173 | 62 | 4 | C0023467 | |
| Disease | serum non-albumin protein measurement | 9.74e-04 | 361 | 62 | 5 | EFO_0004568 | |
| Disease | Tinnitus, wellbeing measurement | 1.10e-03 | 96 | 62 | 3 | EFO_0007869, HP_0000360 | |
| Disease | hematocrit | 1.21e-03 | 1011 | 62 | 8 | EFO_0004348 | |
| Disease | Adenoid Cystic Carcinoma | 1.24e-03 | 100 | 62 | 3 | C0010606 | |
| Disease | Acute monocytic leukemia | 1.37e-03 | 26 | 62 | 2 | C0023465 | |
| Disease | Miller Dieker syndrome | 1.70e-03 | 29 | 62 | 2 | C0265219 | |
| Disease | large artery stroke | 1.75e-03 | 113 | 62 | 3 | EFO_0005524 | |
| Disease | obsolete_red blood cell distribution width | 1.92e-03 | 1347 | 62 | 9 | EFO_0005192 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKKNFYRNETSSQES | 1486 | Q68DN1 | |
| EFEEIDNSTQKQSSY | 176 | Q9UKF5 | |
| SSEQNNNSYETKTPN | 6 | O60825 | |
| QFANTSETNTSDKSF | 496 | Q9H2F5 | |
| QTTVSNSQQAYQEAF | 141 | P31946 | |
| ENYQQSSQSSKAKSA | 361 | Q8IWZ6 | |
| YFKNSSSAKDNSINT | 3366 | P13611 | |
| NKSDAQSTVYSYIQD | 561 | Q9Y3Q7 | |
| STFVFNQKYNTQGSD | 181 | P51684 | |
| LTTASNYNKSESQES | 506 | Q76L83 | |
| VNYSESNSTDSTKSQ | 426 | Q6VN20 | |
| QSSNDSDAYKDQISV | 936 | O60271 | |
| YSSTAQAKNSENKES | 4246 | Q8NEZ4 | |
| AAVSKQSSSTNYTNE | 276 | Q9UHB6 | |
| KQTAFFSSQGQEYTV | 1536 | Q38SD2 | |
| DVFQSYQSATHEQTK | 801 | Q13439 | |
| SAFEVYKSNQAQTVS | 681 | Q9P2D0 | |
| SSQRTDYQKSNFETT | 191 | Q13201 | |
| KQTQTFTTYSDNQSS | 426 | P54652 | |
| QQFAAEYTSKNSSTQ | 6 | Q96JN0 | |
| SKQQSADQDAESAYT | 831 | Q6ZNL6 | |
| TLYSNNSTANKSSVN | 221 | Q7Z3B3 | |
| NSNASNKSVDYSRSQ | 41 | O95447 | |
| FYQNQEDFSTVSSKE | 126 | Q9ULI3 | |
| TSSKNVKEDYDSNSN | 76 | Q30KQ4 | |
| ENESSQNTSSTVQYS | 746 | P40189 | |
| ETSSNKSFENKYQEV | 501 | Q92953 | |
| NINFSESIQNYTDKS | 616 | P54132 | |
| DTENQNNKSVKYTTN | 296 | Q9BQI3 | |
| YSSGNQNEKQIVTTD | 341 | P09958 | |
| SSAKSNYAQFISNTS | 2886 | Q8N3K9 | |
| FYSTSISENNTNITK | 1986 | Q8TDW7 | |
| ASQDAVTTSQSQYFS | 311 | Q8IYT3 | |
| NQTDASATKSYENLA | 441 | Q9UJC3 | |
| TTQNEKYFENSAETD | 2341 | Q9C0D2 | |
| ATTQSNYKSTDQEFQ | 806 | Q02224 | |
| FVNYTKTNSTVTKSN | 106 | Q6P995 | |
| FSFQAKQESASSQTY | 906 | Q56UN5 | |
| ISNENSVNYKNESSA | 901 | Q8TE73 | |
| NSSQEKSKNYSENTD | 306 | Q9BVI0 | |
| TIDFLNSKENTYTDN | 1341 | P56715 | |
| NSKENTYTDNLDSTE | 1346 | P56715 | |
| STDNSLSSQNYISQK | 581 | Q96PC5 | |
| TCVKFSNTTYTTNSQ | 236 | Q9UQF0 | |
| SATTQQENSYGKAVS | 406 | O15061 | |
| QENSYGKAVSSQTNV | 411 | O15061 | |
| QNSTAASTKYDVFRQ | 736 | Q9UMZ2 | |
| FTQVQTIQYSNSEDK | 296 | Q05397 | |
| KITQASQSQESEDYS | 381 | Q00987 | |
| DSQHVSSVTQNQKQY | 391 | P51825 | |
| SSVTQNQKQYDTSSK | 396 | P51825 | |
| NTAVAEFFKSNQTTT | 66 | Q9H9A5 | |
| SQDSSSNNYKSIFLQ | 766 | Q8NB49 | |
| SSEYFQSLFTNKENE | 51 | Q9ULJ3 | |
| QDEEFKDYSTQTAQT | 481 | Q6IEE8 | |
| FKETEFTTVTAYQNQ | 251 | Q9Y458 | |
| SQEQYERNKSSSSSS | 41 | Q8WWA1 | |
| TSSYSQVRNKAQQTF | 976 | Q14997 | |
| SVNSKYEDEQSLNST | 281 | Q9H6N6 | |
| FSKQDDSQSSNQFSL | 241 | O43543 | |
| NSQVDFYNSTQIQSD | 606 | Q5SVZ6 | |
| NNFYSTEVSVSSTEN | 666 | Q8NAP3 | |
| TENFQIKQDSSTGSY | 266 | Q99614 | |
| STTNSKENLSDSNYS | 526 | A8MPX8 | |
| SSQLEDSYNQVQSFS | 2821 | Q14789 | |
| QTNYSKTFQRSNVDF | 316 | Q8N987 |